Real-world effectiveness of early molnupiravir or nirmatrelvir–ritonavir in hospitalised patients with COVID-19 without supplemental oxygen requirement on admission during Hong Kong's omicron BA.2 wave: a retrospective cohort study
Carlos King Ho Wong, Ivan Chi Ho Au, Kristy T. K. Lau, Eric H. Y. Lau, Benjamin J. Cowling, GM Leung
Topics & Concepts
Coronavirus disease 2019 (COVID-19)MedicineRetrospective cohort studyCohortRitonavir2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Emergency medicinePediatricsInternal medicineVirologyHuman immunodeficiency virus (HIV)Viral loadDiseaseInfectious disease (medical specialty)Antiretroviral therapyOutbreakSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesSARS-CoV-2 detection and testing